Navigation Links
Neogen Named to Fortune's List of 40 Stocks 'To Retire On'
Date:6/18/2009

LANSING, Mich., June 18 /PRNewswire-FirstCall/ -- Fortune Magazine has named Neogen Corporation (Nasdaq: NEOG) as a selection in its annual list of the "40 best stocks to retire on."

Fortune first launched its Fortune 40 list in 2002, stating: "We wanted to assemble a diversified, dependable portfolio of stocks for the long term - a selection that could soar when the market did but also hold steady during darker times."

"We are pleased any time we receive independent recognition of Neogen's outstanding performance, and especially when it comes from a source as trusted as Fortune," said James Herbert, Neogen's CEO. "In our opinion, this list represents a valuable source of information for the investment community to help identify companies that are succeeding in a very difficult economic environment."

In making its selection, Fortune said: "Newcomers include biotech Neogen (NEOG), which sells an array of products focused on food safety from farm to factory, including test kits that help foodmakers detect allergens, toxins, and bacteria like E. coli. This business should benefit from increased regulation and growing consumer concern about the food supply. The company, which boasts zero debt, posted its 64th consecutive profitable quarter in March."

"This is one of the few companies that has grown through this entire [economic] mess, and we think it gets easier for them to grow from here," Steven Crowley of Craig-Hallum Capital Group told Fortune. Crowley said he expects Neogen's revenues to grow 10% and earnings to increase by 13% over the next year.

Fortune said that its Fortune 40, which is updated annually, has averaged 10% annualized returns since its inception in 2002, nearly doubling the S&P's 5.1% over the same time period
'/>"/>

SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Neogen Partners With Chinese Government
2. Neogen Develops Quickest Single Test for Beta-Lactams and Tetracyclines in Milk
3. Neogen Reports Record Third Quarter
4. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results Conference Call
5. NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
6. NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
7. Neogen Names New Senior Science Officer; Added to S&P Index
8. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
9. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
10. Neogen Reports Best Quarter in Its 26-Year History
11. Neogen Announces New Share Repurchase Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...KEN, N.J., Dec. 2 According to the...rcent of Americans diagnosed with diabetes already...c retinopathy, damage to the retina caused by leak...people with diabetes and is one of the most feared...t of all patients who,ve had diabetes for 10 years...
(Date:12/1/2009)... NEW YORK, Dec. 1 Reportlinker.com...ailable in its catalogue: ,, Industrial Enzyme...rtlinker.com/p0164431/Industrial-Enzymes---A-Globa...ket is an oligopoly with few strong players and a ...tivities. Keen competition and commoditization cha...
(Date:12/1/2009)...Former Majority Leader Richard Gephardt Brings Tog...Biotech Communities for "Best and Brightest Forum... Dec. 1 Several of New ...als, research, medicine and technology gathered to...mportance of medical innovation in New Jersey, and...
(Date:12/1/2009)...RANCISCO, Dec. 1 The Burrill Biote...he value it lost in October. The Select,s gain of ...nth for the general markets with the Dow up 6.5 pe...gains held firm in the final two trading days of t...hanksgiving holiday shopping and Dubai,s reported ...
Breaking Biology Technology:Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4
... a biotech company, raising money is a saga that n...ve to do two things: execute on the timely achieve... investors and look at the structuring of your nex...from. Most angel investors aren,t repetitive inves...st VCs usually commit for two or more rounds but m...
neuronfarm
...to-based Millennium Research Group predicts the ...es, Europe and Japan will grow by 15 percent annua...ufacturers profiled in Millennium,s study, entitle...ons 2005," include Pfizer, Shire Pharmaceuticals a...market that generated more than $1.3 billion last ...
Other Biology Technology:Financing of biotech companies so far in 2005: A Midwest odyssey 2Financing of biotech companies so far in 2005: A Midwest odyssey 3Financing of biotech companies so far in 2005: A Midwest odyssey 4Financing of biotech companies so far in 2005: A Midwest odyssey 5Alzheimer's drug market to hit $5.5 billion by 2009, study says 2
(Date:12/1/2009)...s National Primate Research Center, Emory Universi...ic prairie voles, an important step toward unlocki...e application of this technology will enable scien...hat will help identify the brain mechanisms of soc...is advancement may also have important implication...
(Date:12/1/2009)...te University cancer researchers have developed a ... cells and blocks the growth of new tumor blood ve...ned to kill cancer cells oncolytic viruses might... if they also carry a gene for a protein that inhi...asculostatin, is normally produced in the brain. I...
(Date:12/1/2009)...c. 1 iQor, a global provider of bu...luded in the 2009 InfoWorld 100 Awards Top 100 I...stem, TeQ21. This was the first submission for iQo...is prestigious list of companies," said Vikas Kapo...y transforming the way we do business, allowing us...
Breaking Biology News(10 mins):Yerkes researchers create first transgenic prairie voles 2Tumor-attacking virus strikes with 'one-two punch' 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Its Time to Clean Up This Mess 3A Texas Surgeon Points Out Numerous Flaws in American Health Care Industry 50619 1Its Time to Clean Up This Mess 3A Texas Surgeon Points Out Numerous Flaws in American Health Care Industry 50619 2Current Status of the Development Programs of New Indications and Formulations for Aricept 28R 29 for Enhancing Patient Value 4675 1Current Status of the Development Programs of New Indications and Formulations for Aricept 28R 29 for Enhancing Patient Value 4675 2Current Status of the Development Programs of New Indications and Formulations for Aricept 28R 29 for Enhancing Patient Value 4675 3Furniture Online 26apos 3Bs New Look Unveiled 50617 1Furniture Online 26apos 3Bs New Look Unveiled 50617 2
... easy to use, and rapid alternative to blood-based... testing according to a new MUHC study. The study...est is 100 per cent accurate and patients?preferre..., a postdoctoral fellow at the McGill University H... individuals for HIV infection at the Mahatma Gand...
...rom the University of Sheffield have received join...e Research Council (EPSRC) and the Ministry of Def...ct bacteria. The new method will use a polymer whi...rs bacteria, allowing scientists to easily identif...onal methodologies. , The new technology will be...
...l climate change causes changes in the species com...ow coastal oceans. This applies also to fish popul...een global warming and declining fish stocks were ...der to estimate future changes, it is essential to...ater temperature on the biology of organisms under...
Other Biology News:Rapid oral HIV test shows great promise according to MUHC-led research 2How fish species suffer as a result of warmer waters 2
3' RACE Adapter Primer from Invitrogen
...ic peptide derived from the N-terminal region of t...teins. Specificity: Specific for the human occlud... Caco-2 cell lysates). Reactivity with rat mouse ...tern blotting Immunohistochemistry Immunofluoresce...
ARCA (Anti Reverse Cap Analog) from Ambion
TRIzol LS Reagent from Invitrogen
Biology Products: